Global Cancer Technology is a fast growing Medical Technology company that provides Products, Partnerships and Services for the world-wide medical and oncology market. The company is acquiring Patents and Intellectual Property rights as well as exclusive distribution agreements to introduce breakthrough technologies into the medical community.
Global Cancer Technology is establishing three subsidiary companies to bring to market novel and breakthrough medical technologies:
NanoMed Transport, Inc. has 2 separate pharma developments underway. The first is a modification of UCN-01 for improved PK and the second involves attaching a prodrug to a nanocrystal scintillator that is radiosurgically activated
Nano Med Tracking, Inc. licenses a patented process to label and track hospital instruments utilizing nano Quantum Dots.
Phantom Technologies, Inc. is developing a unique phantom to standardize procedures in Magnetic Resonance Therpy (MRT)
Global Cancer Technology
Global Cancer Technology is the world-wide exclusive distributor of the RGS Orbiter, produced by American Radiosurgery, Inc. The RGS Orbiter is the first device that uses gamma knife technology®to treat tumors of the brain as well as the rest of the body.
Global Cancer Technology also provides Partnerships to finance and install radiosurgery programs and cyclotrons for the production of radioactive isotopes used in PET/CT imaging.
Your Questions & Comments are important to us. Connect with us for any questions or Inquiries or call (858) 451-6173
NanoDrug Transport, Inc.
The Company is finalizing patent acquisition and an exclusive development contract with Scientists from the UCSD
The Rotating Gamma System Orbiter™ -Exclusive distribution agreement for this device, which is the first gamma knife
NanoMed Tracking, Inc.
NanoMed Tracking(2017) -(Subsidiary of GCT) An innovative and unique technology to track hospital instruments